Skip to content

When esketamine are combined, cyclopofol inhibits half of the effective dose of bronchoscopy in older patients

When esketamine are combined, cyclopofol inhibits half of the effective dose of bronchoscopy in older patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093914
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia

Interventions

Cyproheptadine first group:Increase or decrease of cyclophosphamide
Cyproheptadine second group:Increase or decrease of cyclophosphamide

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Patient who underwent elective fibroid surgery at the Hospital of Guangdong Medical University; 2 American Academy of Anesthesiologists (ASA) grade II / III patients, age 45-80 years, gender,; 3.BMI 18-30kg / m^2, oxygen degree of saturation (SpO2) > 95%; 4.The estimated operation time was 5 min-15 min. 5 Be able to understand and adhere to this study and sign a written informed consent; No surgical and anaesthesia contraindications;

Exclusion criteria

Exclusion criteria: 1 Excessive obesity (body mass index > 30 kg / m^2); 2 Patients with severe respiratory circulation, with severe narrowing of the main airways; 3.Have a serious mental nervous system disease, severe depression; 4. Patients with a long history of benzodiazepine use; 5. patients with myasthenia gravis Patients with estimated duration of fiberoptic bronchoscopy longer than 30;

Design outcomes

Primary

MeasureTime frame
Mirror reaction;

Countries

China

Contacts

Public ContactCao Dianqing

Affiliated Hospital of Guangdong Medical University

caodq-95@163.com+86 136 0038 6634

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026